CCL2 and early-onset autosomal dominant Alzheimer disease: Interestingly, u osób chorujących na Alzheimera obserwuje się wzrost liczby klasycznych, prozapalnychmonocytów, jako skutek wysokiego stężenia MCP-1 wsurowicy [35].in patients suffering from Alzheimer’s disease an increase in the number of classical pro-inflammatory monocytes is observed as a result of high serum MCP-1 concentration [62].